Fractional Executive Leadership
For companies that need seasoned leadership without the full-time overhead, Tennyson offers fractional C-suite services tailored to your growth stage. Whether you’re seeking a strategic CFO to guide fundraising, a CBO to shape partnerships, or interim CEO support during transition, we embed deeply and operate as part of your team—not just as advisors.
Roles supported:
- Chief Financial Officer (CFO)
- Chief Business Officer (CBO)
- Chief Executive Officer (CEO)
Business Development Strategy & Licensing Support
From early-stage asset positioning to late-stage deal execution, we help biopharma companies navigate the complex terrain of business development. Our approach blends scientific fluency with commercial insight, ensuring your story resonates with partners, investors, and acquirers.
Services include:
- Asset evaluation and positioning
- Partner outreach strategy
- Licensing and co-development deal structuring
- Investor pitch refinement
Transaction Advisory
Whether you’re preparing for a Series A, exploring M&A, or entering a strategic collaboration, Tennyson provides hands-on support throughout the transaction lifecycle. We help you anticipate roadblocks, align stakeholders, and negotiate from a position of strength.
Focus areas:
- Fundraising strategy and preparation
- M&A readiness and execution
- Strategic partnership development
- Due diligence coordination
Embedded Collaboration, Not Just Consulting
We don’t deliver slide decks and walk away. Tennyson operates as a strategic partner—joining internal meetings, shaping real-time decisions, and helping you build the infrastructure that lasts beyond the next milestone.
“In biotech, execution is everything. The science may be novel, but success depends on clarity, alignment, and momentum. That’s where we come in.”
— Michael Broxson, Founder